Evidence-Based Risk Stratification to Target Therapies in Acute Coronary Syndromes
- 24 September 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (13) , 1588-1591
- https://doi.org/10.1161/01.cir.0000030416.80014.f4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Identification of patients at high risk for death and cardiac ischemic events after hospital dischargeAmerican Heart Journal, 2002
- An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUSEuropean Heart Journal, 2002
- Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial InfarctionResults From a Randomized TrialJAMA, 2001
- Elevation in serum troponin I predicts the benefit of tirofiban.Journal of Thrombosis and Thrombolysis, 2001
- Enoxaparin in Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction: Treatment Benefits in Prespecified SubgroupsJournal of Thrombosis and Thrombolysis, 2001
- Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudyJournal of the American College of Cardiology, 2000
- The TIMI Risk Score for Unstable Angina/Non–ST Elevation MIJAMA, 2000
- Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofibanThe Lancet, 1999
- Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T LevelsNew England Journal of Medicine, 1999
- Troponin T Identifies Patients With Unstable Coronary Artery Disease Who Benefit From Long-Term Antithrombotic ProtectionJournal of the American College of Cardiology, 1997